- Home
- Companies
- Regenhu
- Applications
- 3D Bioprinters - Cellular Drug ...
3D Bioprinters - Cellular Drug Discovery Models - Medical / Health Care - Medical Equipment
Using 3D bioprinters can create physiologically-relevant cellular disease models to test therapeutic hypothesis by accurately and reproducibly controlling the deposition of different cell types and support materials, providing a viable technology solution for drug discovery projects. Our scientific advisors are best placed to provide further information.
ADAPTIVE AND FLEXIBLE PRINTING TECHNOLOGIES
Configuring the instrument with a range of alternative printing technologies, which can all be used during one print protocol, provides the flexibility to use the best technology to achieve printing precision and high cell viability.
PHYSIOLOGICAL RELEVANCE
Using an automated process to accurately place different cell types, biomaterials and bioactives in layers, results in more physiologically-relevant model constructs.
REPRODUCIBILITY
Using our high-precision liquid dispensing robotic 3D Bioprinting Station results in the repeatable production of cellular models across plates and within days, reducing one of the quality variables of non-automated methods.
Our 3D bioprinters are widely used in building cellular discovery models, and are personally configured to your specific research needs.
The R-GEN 200 Bioprinting Station is designed for printing cellular constructs, with up to five printhead tools with individual cartridge and workzone temperature controls, a biosafety enclosure and physiological temperature-controlled working zone.
Three separate printing technologies supplied as part of the Drug Discovery R-GEN instrument, each with separate temperature control, provide printing options from droplets to high-precision biomaterial deposition to yield high cell viability and accuracy of cellular placement.